Stockchase Opinions

Jason Del Vicario Chemed Corporation CHE-N TOP PICK Mar 08, 2021

They have been around for over 100 years. They survived the depression. They have interests in hospices and cleaning. They have dental supply as well. They have a long history of raising dividends and buybacks. He'd like to see it lower before buying. (Analysts’ price target is $595.00)

$430.840

Stock price when the opinion was issued

Healthcare
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

You might be interested:

PAST TOP PICK
(A Top Pick Mar 08/21, Up 11%) Doesn't own stock anymore even though has recommended it to investors. Flawed corporate governance. Management overpaid. Will not buy in the future.
BUY

She added more. The hospice business is growing double-digits.